Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.22.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Operating activities:    
Net loss $ (7,598) $ (4,943)
Adjustments to reconcile net loss to net cash used in operating activities    
Depreciation and amortization 462 502
Changes in allowance for doubtful accounts (7) 48
Gain on revaluation of warrant liabilities (899) (886)
Stock-based compensation expense 1,081 875
Common stock contribution to 401(k) plan 103 107
Unrealized loss on foreign currency transactions 972 372
Changes in operating assets and liabilities:    
Accounts receivable 1,228 420
Inventories (1,221) (136)
Prepaid expenses, and other assets, current and noncurrent (318) (135)
Accounts payable (1,048) (73)
Accrued, lease and other liabilities (836) (304)
Deferred revenues (373) (354)
Net cash used in operating activities (8,454) (5,606)
Financing activities:    
Proceeds from issuance of common stock and warrants, net 0 37,295
Proceeds from exercise of warrants 0 1,417
Net cash provided by financing activities 0 38,712
Effect of exchange rate changes on cash (40) (30)
Net (decrease) increase in cash (8,494) 33,076
Cash at beginning of period 40,406 12,862
Cash at end of period 31,912 45,938
Cash paid for income taxes 4 0
Supplemental disclosure of cash flow activities    
Cash paid for interest 55 46
Supplemental disclosure of non-cash activities    
Fair value of warrants issued upon equity financing 0 1,936
Reclassification of warrant liability to equity upon exercise of warrants 0 2,461
Transfer of inventory to property and equipment 175 162
Share issuance for common stock contribution to 401(k) plan 176 152
Gain on forgiveness of note payable $ 0 $ (1,099)